TIGIT and breast cancer: In a variety of tumor bearing mice models (B16 melanoma, CT26 CC, 4T1 BC lung metastasis model mice, among others), TIGIT was more specifically associated with tumor progression in NK cells than in other cells, and TIGIT+ NK cells acquired an exhaustion phenotype, with reduced effector function and antitumor potential.